infection; bacteremia; surveillance cultures Infections are one of the leading causes of complications in patients treated with high-dose chemotherapy. 1, 2 Bacteremias are reported in 20% of patients with neutropenic fever, and are sometimes associated with dramatic complications such as septic shock, multiorgan failure or even death. 2, 3 Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk of developing bacteremias and infections, in general, because of prolonged neutropenia, mucositis, graft-versus-host disease (GVHD), CMV infection and indwelling catheters. Colonization with various organisms is thought to often precede the development of infections. [4] [5] [6] [7] [8] Therefore, surveillance cultures are often performed in HSCT recipients. In addition, prophylactic antibiotics and antifungal agents are used to try to prevent the development of uncontrolled infections, but their value is still debated because prophylaxis clearly causes the emergence of resistant strains leading to real concerns for the treatment and survival of severely immunosuppressed patients.
Therefore, we undertook the present retrospective study in 622 HSCT recipients: (1) to determine the incidence, timing and etiology of bacteremias in our patient population; and (2) to examine the ability of routine surveillance cultures to predict bacteremias.
Patients and methods

Patients
The study population consisted of 622 transplants performed in our BMT unit between 1982 and 2001. There were 256 allografts (41%) and 366 autografts (59%). Allografts included 106 related donor bone marrow (17% of all patients) and 86 PBSC transplants (14%), as well as 55 unrelated donor bone marrow (9%), five PBSC (0.8%) and four cord blood (0.6%) transplants. Autografts included 84 BMT (13%) and 282 PBSCT (46%). There were 283 females and 339 males. Median age at transplant was 40 years, ranging from 1 to 69 years. Patients suffered from non-neoplastic disorders (20) , AML (129), ALL (59), CML (55), MDS (22) , NHL (99), Hodgkin's disease (21) , multiple myeloma (107), breast cancer (70) or other solid tumors (40).
Clinical management
Until engraftment, patients received chlorhexidine mouthwashes, aerosolized amphotericin B, oral ciproflox-acin (500 mg b.i.d., between 1987 and 2000), acyclovir (250 mg/m 2 b.i.d.) and antifungal prophylaxis with itraconazole or fluconazole. Furthermore, all patients were kept in laminar airflow rooms. Clinical examination was performed at least once a day and body temperature was measured every 3 h. In case of fever, above 3813C once or 381C on three consecutive measurements, empirical antibiotherapy was started with a combination of piperacillin þ amikacin (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) , ceftazidime þ vancomycin (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) or cefepim þ amikacin (since 2001).
Microbiology
Routine surveillance cultures (stool, urine, sputum, nose, tongue, throat, skin, vagina or penis, anus and blood) were obtained twice weekly. Before the initiation of antibiotherapy, blood cultures were drawn through each lumen of the central catheter (Hickman or Port-A-Cath) and a peripheral vein. Additional blood cultures were obtained when clinically indicated. Identification and antimicrobial susceptibility testing were performed according to the manufacturer's recommendations by using the SCEPTOR system (BD, Brussels, Belgium) in 1982-1992 or the automated VITEK system since 1993 (BioMerieux, St Louis, MO, USA). MICs were determined and interpretative category results (susceptible, intermediate and resistant) were also routinely provided. Interpretative criteria were based on updated NCCLS (National Committee for Clinical Laboratory Standards) breakpoints. The classification into sensitive and resistant strains was carried out on the basis of MIC.
Definitions and data collection
The 19 years of follow-up were divided into 10 consecutive periods, each including about 60 patients:period 1 (1982 to September 1987, old hospital), period 2 (October 1987 (new hospital) to 1990), period 3 (1991-1992) , period 4 (1993-1994) , period 5 (1995-1996) , period 6 (1997), period 7 (1998), period 8 (1999) , period 9 (2000) and period 10 (2001) .
Bacteria were classified into six categories taking into account both their relative frequency and their biological characteristics. These categories were:(1) streptococci (including pneumococci and enterococci); (2) coagulasenegative staphylococci; (3) other Gram-positive bacteria (including Staphylococcus aureus); (4) anaerobic bacteria (bacteria requiring absence of oxygen for growth, including both strict anaerobes and aerotolerant bacteria); (5) Gramnegative bacteria (including Pseudomonas); and (6) fungi.
According to the definitions of the Infectious Diseases Working Party of the EBMT, bacteremia or fungemia were defined by the isolation of bacteria or fungi from any blood culture in the context of fever or other clinical signs consistent with infection. For coagulase-negative staphylococci, at least two blood cultures were required to be positive.
The total number of bacteremias and fungemias was recorded. For each episode, we investigated whether the responsible agent had been detected in routine surveillance cultures obtained before or after the date of bacteremia or fungemia. The isolates were considered identical if susceptibility testing yielded similar results. This was only possible for bacteremias or fungemias occurring within 60 days of the transplant, that is, mostly during initial hospitalization.
Results
Among the 622 transplants, 404 episodes of bacteremia/ fungemia occurred in 248 patients (Table 1 ). This represents an overall incidence of 0.65 episodes by patient overall or 1.63 episodes by affected patient. These included 171 episodes due to coagulase-negative staphylococci (42%), 129 to Gram-negative bacteria (32%), 48 to streptococci (12%), 33 to other Gram-positive bacteria (8%), nine to anaerobes (2%) and 14 to fungi (3%).
The incidence and type of bacteremia clearly changed during the 10 periods studied, encompassing 20 years ( Table 1 ). The overall incidence of bacteremia decreased over the years (0.92 episode/patient until 1990 vs 0.66 in 1991-1996 vs 0.55 in 1997-2001, Po0.0001). Gram-positive agents outnumbered Gram-negative bacteria by a margin of at least 2:1 throughout the study period except in the last 2 years. In particular, coagulase-negative staphylococci represented less than one-third of all episodes until 1990, then increased to more than 50% of all episodes in the years 1991-1996 before decreasing to less than 30% since Table 1 Bacteremias and fungemias according to year of transplantation Gram-pos  6  5  3  2  6  2  3  1  3  2  3 3  Anaerobes  2  3  0  0  2  0  0  0  2  0  9  Gram-neg  19  11  12  10  17  11  9  7  19  14  129  Fungi  2  3  2  1  2  2  1  0  1  0  1 4  Total  48  49  49  33  64  27  34  22 For the other agents, including fungi, no particular pattern of evolution was evident, but the number of such episodes was quite small. Bacteremias were significantly more frequent in allogeneic compared to autologous transplants. The overall incidence of bacteremia was 0.96 episodes/patient in allogeneic transplants vs 0.44 in autologous transplants (Po0.0001). The incidence of bacteremias in allogeneic transplant recipients did not change over the years, whereas in autologous transplant recipients the number of bacteremias decreased after 1993 following the systematic use of PBSC as the source stem cells (1.04 vs 0.33 episode/patient, before and after 1993, respectively, Po0.0001).
Among the 404 episodes of bacteremia/fungemia, 212 (53%) occurred before patients were discharged from the hospital and 192 (47%) thereafter (Table 2) . About 48% of all episodes took place before day 30 post transplant. For streptococci, anaerobes and fungi, 65, 90 and 64% of events, respectively, occurred before day 30. This proportion was lower (P ¼ 0.001) for coagulase-negative staphylococci, other Gram-positive bacteria and Gram-negative bacteria, with 44, 44 and 36%, respectively, occurring in this early post transplant interval. The incidence of bacteremia remained high well beyond day 100. A clear difference (P ¼ 0.034) appears between allografts and autografts (Table 3) . After autologous transplantation, the majority (59%) of episodes occurred before hospital discharge, that is, essentially during the period of neutropenia. On the other hand, the opposite was true after allogeneic transplantation where only 48% of events took place before discharge.
To determine whether routine surveillance cultures were useful or not to predict bacteremias, we analyzed all episodes occurring before day 60 post transplant to examine whether the responsible agent was detected before or after the first day of bacteremia, or never (Table 4) . There were a total of 218 bacteremic episodes before day 60 (54%), excluding those happening in the nonmyeloablative setting because no routine surveillance cultures were performed in this type of patient. In 109 cases (50%), the agent responsible for the bacteremic episode was present in routine surveillance cultures earlier. Otherwise, the agent was absent in most cases (42%) or only detected after the bacteremic event (8%). Among the various categories of agents, coagulase-negative staphylococci were the only ones to be present in surveillance cultures in advance in the majority of the cases (74%). Streptococci, other Grampositive bacteria and anaerobes, however, were seldom identified in previous surveillance cultures. Gram-negative bacteria (45%) and fungi (60%) were present in surveillance cultures before the infectious episode in about half of the cases. These differences are highly significant (Po0.0001).
Discussion
We conducted a retrospective survey on the incidence, timing and etiology of bacteremias and fungemias in recipients of a hematopoietic stem cell transplant in our unit between 1982 and 2001. A major aim of our study was to examine the ability of routine surveillance cultures to predict the causative agents of bacteremia, one of the most Table 2 Bacteremias and fungemias according to timing of hospitalization and delay after transplantation Streptococci  15  68  7  32  17  65  9  35  Coag-neg staphylococci  40  61  26  39  47  45  58  55  Other Gram-pos  8  57  6  43  6  32  13  68  Anaerobes  2  67  1  33  6  100  0  0  Gram-neg  25  52  23  48  36  44  45  56  Fungi  5  63  3  37  5  83  1  17  Total  95  59  66  41  117  48  126  52 frequent life-threatening infections in neutropenic patients. 9 Indeed, the mortality primarily or secondarily due to infections has been reported to reach 60% in some series of patients undergoing HSCT.
10,11
We identified a high incidence of bacteremia (404 episodes for 622 transplants). This is higher than in the majority of studies, [1] [2] [3] [11] [12] [13] [14] in which the overall incidence ranged from 20 to 62%. This particularly high incidence could be related in part to the length of our follow-up (19 years), whereas many studies only considered the early post transplant period. In addition, the definition of bacteremia was broader in our study. First, we labeled as bacteremia any infectious episode with a positive blood culture, even if another site of infection, such as pneumonia, was also present. Second, in accordance with recent EBMT guidelines, a single (two for coagulase-negative staphylococci) positive blood culture was considered sufficient for establishing the diagnosis. Third, for the purpose of the analysis in relation to surveillance cultures, a single episode with two different agents was counted as two separate episodes.
The total number of bacteremias decreased over time. This observation is in accordance with the literature [1] [2] [3] 9, [11] [12] [13] [15] [16] [17] and may be related to a number of factors. These factors include a reduction in the duration of neutropenia with the more generalized use of myeloid growth factors, use of peripheral blood as the preferred source of stem cells (particularly true for autologous transplants since 1993 in our study) and a larger number of autologous transplants relative to the number of allogeneic transplants. We cannot evoke improvements in preventive strategies, as prophylactic measures for bacterial infections did not change much over time. In particular, quinolone prophylaxis was used during most of our study period (years 1987-2000 , that is, periods 2-9), and it is too early to know whether abandoning such prevention since 2001 will translate into any significant change in the incidence of Gram-negative bacteremias. Among the 404 bacteremic episodes collected, a large number (42%) were due to coagulase-negative staphylococci, but this proportion decreased after 1996. Gram-negative bacteremia represented 32% of all episodes with an increasing incidence of resistant strains in periods 9 and 10. 18 As discussed in our previous study, 18 the introduction of 'selective' decontamination with ciprofloxacin between 1987 and 2000 as well as the use of a combination of a glycopeptide and a third-generation cephalosporin as empiric antibiotherapy may be responsible for this evolution towards more resistant Gramnegative agents. In our experience, about half the bacteremias (48%) occurred before day 30, that is, during neutropenia before engraftment. This was particularly true for streptococci (65%), anaerobes (90%) and fungi (64%), whereas only 40% of bacteremias due to other agents occurred during this early post transplant interval. Therefore, neutropenia appears to be a major risk factor for bacteremia/fungemia in our study despite the administration of fungal and bacterial prophylaxis. Other studies also emphasize this risk factor, although it is still a matter of some debate. 1, 2, 11, 13, 15, 16, 19 Other possible explanations during the first 30 days include mucositis and the presence of central venous catheters that have both been linked to the occurrence of bacteremia. 1, 3, 9, 11, 14, 20, 21 Contrary to autografts, allografts were more frequently associated with later bacteremias, after hospital discharge, and thus after engraftment (127 vs 117 events). Therefore, after allogeneic transplantation, neutropenia does not appear to be the most important risk factor. This would suggest that late bacteremias are related to persistent immunosuppression, particularly in the setting of chronic GVHD. 22 Indeed, it is not surprising to observe that late bacteremias were almost exclusively encountered in recipients of an allogeneic transplant or in patients experiencing relapse and reinduction chemotherapy.
The interest and cost-effectiveness of routine surveillance culturing has always been controversial and is not well established to our knowledge. [4] [5] [6] [7] [8] [23] [24] [25] [26] Our study shows that routine surveillance cultures can predict the etiology of a bacteremia in 50% of cases. For coagulase-negative staphylococci, the predictive value of such cultures is, in fact, quite low because of the very high rate of colonization observed in our patients (77%). Furthermore, routine surveillance cultures were unable to predict bacteremia with streptococci or anaerobes, which occurred mostly before day 30, the period during which we performed such cultures. We can therefore conclude that for these categories of bacteria, routine surveillance cultures are not useful and are probably not cost-effective. However, surveillance cultures were more predictive for episodes associated with Gram-negative bacteria or fungi. For fungi, surveillance cultures are mainly useful in identifying colonizing strains, which could require more aggressive antifungal therapy, whereas fungal susceptibility testing is less predictive of clinical response to antifungal agents. For Gram-negative bacteria, previously established sensitivities to antibiotics may be most useful in implementing immediate successful therapy. In addition, we have previously observed that invasive Gram-negative bacteria were overall less susceptible to antibiotics than colonizing bacteria 18 and appropriately targeting them therefore appears critical. However, even if we take the conservative figure of 30% resistance to our standard empiric antibiotic regimen, only a very small number of Gram-negative bacteremias (30% of 28 episodes ¼ 8 episodes over 19 years, that is, 13% of Gram-negative bacteremias or 2% of all bacteremias) would be better managed with the help of surveillance cultures. This would certainly not be costeffective.
Another point of interest with respect to routine surveillance cultures remains that they contribute to determining the bacteriological ecology of a transplant unit and therefore allow the development of the most appropriate prophylactic and empirical antibiotic regimens to allow efficiency and to prevent the emergence of resistant strains. This has brought about major changes in antibiotic policy in our unit. 18 
